Data Insights

Eladocagene exuparvovec by PTC Therapeutics for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency: Likelihood of Approval

Eladocagene exuparvovec is under clinical development by PTC Therapeutics and currently in Pre-Registration for Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency....

Likelihood of Approval and Phase Transition Success Rate Model - Eladocagene Exuparvovec in Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency

Data Insights

Vatiquinone by PTC Therapeutics for MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes): Likelihood of Approval

Vatiquinone is under clinical development by PTC Therapeutics and currently in Phase III for MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis...

Likelihood of Approval and Phase Transition Success Rate Model - Vatiquinone in MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes)

Data Insights

Vatiquinone by PTC Therapeutics for Subacute Necrotizing Encephalomyelopathy (Leigh Disease): Likelihood of Approval

Vatiquinone is under clinical development by PTC Therapeutics and currently in Phase III for Subacute Necrotizing Encephalomyelopathy (Leigh Disease). According...

Likelihood of Approval and Phase Transition Success Rate Model - Vatiquinone in Subacute Necrotizing Encephalomyelopathy (Leigh Disease)

Data Insights

Vatiquinone by PTC Therapeutics for Friedreich Ataxia: Likelihood of Approval

Vatiquinone is under clinical development by PTC Therapeutics and currently in Phase III for Friedreich Ataxia. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Vatiquinone in Friedreich Ataxia

Data Insights

Sepiapterin by PTC Therapeutics for Phenylketonuria (PKU): Likelihood of Approval

Sepiapterin is under clinical development by PTC Therapeutics and currently in Pre-Registration for Phenylketonuria (PKU). According to GlobalData, Pre-Registration drugs...

Likelihood of Approval and Phase Transition Success Rate Model - Sepiapterin in Phenylketonuria (PKU)

Data Insights

Ataluren by PTC Therapeutics for Duchenne Muscular Dystrophy: Likelihood of Approval

Ataluren is under clinical development by PTC Therapeutics and currently in Pre-Registration for Duchenne Muscular Dystrophy. According to GlobalData, Pre-Registration...

Data Insights

Vatiquinone by PTC Therapeutics for MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes): Likelihood of Approval

Vatiquinone is under clinical development by PTC Therapeutics and currently in Phase III for MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis...

Data Insights

Vatiquinone by PTC Therapeutics for Subacute Necrotizing Encephalomyelopathy (Leigh Disease): Likelihood of Approval

Vatiquinone is under clinical development by PTC Therapeutics and currently in Phase III for Subacute Necrotizing Encephalomyelopathy (Leigh Disease). According...

Data Insights

Vatiquinone by PTC Therapeutics for Friedreich Ataxia: Likelihood of Approval

Vatiquinone is under clinical development by PTC Therapeutics and currently in Phase III for Friedreich Ataxia. According to GlobalData, Phase...

Data Insights

PTC-607 by PTC Therapeutics for Huntington Disease: Likelihood of Approval

PTC-607 is under clinical development by PTC Therapeutics and currently in Phase I for Huntington Disease. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - PTC-607 in Huntington Disease